These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10767967)

  • 1. Effect of the alpha-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus.
    Nelson RW; Robertson J; Feldman EC; Briggs C
    J Am Vet Med Assoc; 2000 Apr; 216(8):1265-9. PubMed ID: 10767967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary insoluble fiber on control of glycemia in dogs with naturally acquired diabetes mellitus.
    Nelson RW; Duesberg CA; Ford SL; Feldman EC; Davenport DJ; Kiernan C; Neal L
    J Am Vet Med Assoc; 1998 Feb; 212(3):380-6. PubMed ID: 9470048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.
    Lin SD; Wang JS; Hsu SR; Sheu WH; Tu ST; Lee IT; Su SL; Lin SY; Wang SY; Hsieh MC
    J Diabetes Complications; 2011; 25(5):332-8. PubMed ID: 21813293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose.
    Kihara Y; Ogami Y; Tabaru A; Unoki H; Otsuki M
    J Gastroenterol; 1997 Dec; 32(6):777-82. PubMed ID: 9430016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes.
    Wolever TM; Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Int J Obes Relat Metab Disord; 1997 Sep; 21(9):756-63. PubMed ID: 9376887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of history and physical examination findings for assessing control of glycemia in dogs with diabetes mellitus: 53 cases (1995-1998).
    Briggs CE; Nelson RW; Feldman EC; Elliott DA; Neal LA
    J Am Vet Med Assoc; 2000 Jul; 217(1):48-53. PubMed ID: 10909446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes.
    Salman S; Salman F; Satman I; Yilmaz Y; Ozer E; Sengül A; Demirel HO; Karşidağ K; Dinççağ N; Yilmaz MT
    Curr Med Res Opin; 2001; 16(4):296-306. PubMed ID: 11268714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral chromium picolinate and control of glycemia in insulin-treated diabetic dogs.
    Schachter S; Nelson RW; Kirk CA
    J Vet Intern Med; 2001; 15(4):379-84. PubMed ID: 11467597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients.
    Vichayanrat A; Ploybutr S; Tunlakit M; Watanakejorn P
    Diabetes Res Clin Pract; 2002 Feb; 55(2):99-103. PubMed ID: 11796175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
    Hariya N; Mochizuki K; Inoue S; Saito M; Fuchigami M; Goda T; Osonoi T
    Drugs R D; 2014 Sep; 14(3):177-84. PubMed ID: 25079671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated hemoglobin concentrations in the blood of healthy dogs and dogs with naturally developing diabetes mellitus, pancreatic beta-cell neoplasia, hyperadrenocorticism, and anemia.
    Elliott DA; Nelson RW; Feldman EC; Neal LA
    J Am Vet Med Assoc; 1997 Sep; 211(6):723-7. PubMed ID: 9301742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH; Wudy A; Eberlein G; Quast C
    Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of day-to-day variability of serial blood glucose concentration curves in diabetic dogs.
    Fleeman LM; Rand JS
    J Am Vet Med Assoc; 2003 Feb; 222(3):317-21. PubMed ID: 12564593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998).
    Hess RS; Ward CR
    J Am Vet Med Assoc; 2000 Jan; 216(2):217-21. PubMed ID: 10649757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detemir insulin for the treatment of diabetes mellitus in dogs.
    Fracassi F; Corradini S; Hafner M; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    J Am Vet Med Assoc; 2015 Jul; 247(1):73-8. PubMed ID: 26086231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, open-label study comparing the efficacy and safety of preprandial and prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus.
    Yang G; Li C; Gong Y; Li J; Cheng X; Tian H
    Diabetes Technol Ther; 2013 Jun; 15(6):513-9. PubMed ID: 23530576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study.
    Chen YH; Tarng DC; Chen HS
    PLoS One; 2016; 11(11):e0165750. PubMed ID: 27812149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.